TransEnterix gaining traction with solid Senhance sales so far in 2018

Posted in Medical Device,

May 08, 2018 • 2 min read

TransEnterix just announced Q1 earnings with an additional update on Senhance system sales up to this point in Q2, which ends June 30th. On initial glance, you can tell the TransEnterix sales team has done a nice job shortening the typical sales cycle for capital equipment of this dollar amount. ...

How much does MiMedx pay physicians? We don't know and that's the problem

Posted in Medical Device,

May 08, 2018 • 3 min read

MiMedx not reporting Open Payment data has been written about at length. We asked the question in a post earlier this year and the Wall Street Journal had a fantastic piece asking the same questions a month later. With all of the attention being given to MiMedx and their business practices, one would think any physician receiving payments from them would self report those payments. ...

Acclarent Launches TruDi 3D Mapping for Balloon Sinuplasty Surgeries

Posted in Medical Device

May 07, 2018 • 2 min read

Acclarent announced the US commercial launch of TruDi, a real-time, three-dimensional (3D) navigation system for ENT procedures performed in the operating room and surgeon’s office. The system was developed in collaborations with another Johnson & Johnson company, Biosense Webster, who develops technology used to treat heart rhythm disorders. ...

Intuitive Surgical continues to target General Surgery with inguinal hernia study

Posted in Medical Device,

May 06, 2018 • 3 min read

One of Intuitive Surgical's four priorities in 2018 is to continue adoption in General Surgery. Through the first quarter of the year, the company is well on their way to over-achieving their four priorities. One way Intuitive can ensure their adoption and growth in general surgery is to show efficacy with their da Vinci versus traditional open procedures. ...

Zimmer Biomet Still Haunted By Supply Chain

Posted in Medical Device

May 02, 2018 • 3 min read

Zimmer Biomet has struggled with supply chain issues going back to their 58 page warning letter from the FDA in 2016. From their old CEO, David Dvorak, to their new one, Bryan Hanson, improving operational efficiencies has been the top priority. ...

Strong PROPEL Showing Lifts Intersect ENT in Q1

Posted in Medical Device

May 02, 2018 • 3 min read

Intersect ENT continued their solid revenue growth during Q1 of 2018, with total revenue of $24.7 million compared to $20.5 million in the same quarter of 2017. Overall, the company grew revenue 21% in the quarter. ...